nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—CYP2D6—Alzheimer's disease	0.217	1	CbGaD
Erlotinib—CYP2D6—Rivastigmine—Alzheimer's disease	0.0699	0.264	CbGbCtD
Erlotinib—CYP2D6—Donepezil—Alzheimer's disease	0.0559	0.211	CbGbCtD
Erlotinib—CYP3A4—Rivastigmine—Alzheimer's disease	0.0445	0.168	CbGbCtD
Erlotinib—CYP2D6—Galantamine—Alzheimer's disease	0.036	0.136	CbGbCtD
Erlotinib—CYP3A4—Donepezil—Alzheimer's disease	0.0356	0.134	CbGbCtD
Erlotinib—CYP3A4—Galantamine—Alzheimer's disease	0.0229	0.0865	CbGbCtD
Erlotinib—ULK3—forebrain—Alzheimer's disease	0.00215	0.0246	CbGeAlD
Erlotinib—EGFR—telencephalon—Alzheimer's disease	0.00213	0.0244	CbGeAlD
Erlotinib—PIP4K2C—telencephalon—Alzheimer's disease	0.00207	0.0237	CbGeAlD
Erlotinib—ULK3—telencephalon—Alzheimer's disease	0.00197	0.0226	CbGeAlD
Erlotinib—MKNK1—telencephalon—Alzheimer's disease	0.00186	0.0213	CbGeAlD
Erlotinib—AURKC—nervous system—Alzheimer's disease	0.00185	0.0212	CbGeAlD
Erlotinib—AURKC—central nervous system—Alzheimer's disease	0.00178	0.0204	CbGeAlD
Erlotinib—SLK—telencephalon—Alzheimer's disease	0.00176	0.0202	CbGeAlD
Erlotinib—JAK3—nervous system—Alzheimer's disease	0.00171	0.0196	CbGeAlD
Erlotinib—EPHA6—nervous system—Alzheimer's disease	0.00171	0.0196	CbGeAlD
Erlotinib—Vandetanib—VEGFA—Alzheimer's disease	0.00167	0.745	CrCbGaD
Erlotinib—HIPK4—brain—Alzheimer's disease	0.00166	0.019	CbGeAlD
Erlotinib—JAK3—central nervous system—Alzheimer's disease	0.00165	0.0189	CbGeAlD
Erlotinib—EPHA6—central nervous system—Alzheimer's disease	0.00165	0.0189	CbGeAlD
Erlotinib—LTK—brain—Alzheimer's disease	0.00164	0.0188	CbGeAlD
Erlotinib—JAK3—cerebellum—Alzheimer's disease	0.00161	0.0185	CbGeAlD
Erlotinib—MAP3K19—nervous system—Alzheimer's disease	0.00156	0.0178	CbGeAlD
Erlotinib—MAP3K19—central nervous system—Alzheimer's disease	0.0015	0.0172	CbGeAlD
Erlotinib—TNK1—cerebellum—Alzheimer's disease	0.00148	0.017	CbGeAlD
Erlotinib—AURKC—brain—Alzheimer's disease	0.00141	0.0162	CbGeAlD
Erlotinib—MAP2K5—telencephalon—Alzheimer's disease	0.00137	0.0157	CbGeAlD
Erlotinib—JAK3—brain—Alzheimer's disease	0.00131	0.015	CbGeAlD
Erlotinib—EPHA6—brain—Alzheimer's disease	0.00131	0.015	CbGeAlD
Erlotinib—ABL1—embryo—Alzheimer's disease	0.0013	0.0149	CbGeAlD
Erlotinib—FLT3—cerebellum—Alzheimer's disease	0.00127	0.0146	CbGeAlD
Erlotinib—PIP4K2C—nervous system—Alzheimer's disease	0.00122	0.014	CbGeAlD
Erlotinib—ABL2—cerebellum—Alzheimer's disease	0.00121	0.0139	CbGeAlD
Erlotinib—TNK1—brain—Alzheimer's disease	0.0012	0.0138	CbGeAlD
Erlotinib—MAP3K19—brain—Alzheimer's disease	0.00119	0.0136	CbGeAlD
Erlotinib—EGFR—cerebellum—Alzheimer's disease	0.00119	0.0136	CbGeAlD
Erlotinib—PIP4K2C—central nervous system—Alzheimer's disease	0.00118	0.0135	CbGeAlD
Erlotinib—ULK3—nervous system—Alzheimer's disease	0.00117	0.0134	CbGeAlD
Erlotinib—SLCO2B1—forebrain—Alzheimer's disease	0.00116	0.0132	CbGeAlD
Erlotinib—PIP4K2C—cerebellum—Alzheimer's disease	0.00115	0.0132	CbGeAlD
Erlotinib—ULK3—central nervous system—Alzheimer's disease	0.00112	0.0129	CbGeAlD
Erlotinib—MKNK1—nervous system—Alzheimer's disease	0.0011	0.0126	CbGeAlD
Erlotinib—ULK3—cerebellum—Alzheimer's disease	0.0011	0.0126	CbGeAlD
Erlotinib—SLCO2B1—telencephalon—Alzheimer's disease	0.00106	0.0122	CbGeAlD
Erlotinib—MKNK1—central nervous system—Alzheimer's disease	0.00106	0.0121	CbGeAlD
Erlotinib—ABL1—telencephalon—Alzheimer's disease	0.00105	0.0121	CbGeAlD
Erlotinib—MKNK1—cerebellum—Alzheimer's disease	0.00103	0.0118	CbGeAlD
Erlotinib—ABL2—brain—Alzheimer's disease	0.000986	0.0113	CbGeAlD
Erlotinib—SLK—cerebellum—Alzheimer's disease	0.000978	0.0112	CbGeAlD
Erlotinib—EGFR—brain—Alzheimer's disease	0.000963	0.011	CbGeAlD
Erlotinib—PIP4K2C—brain—Alzheimer's disease	0.000933	0.0107	CbGeAlD
Erlotinib—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000924	0.00395	CcSEcCtD
Erlotinib—Haemoglobin—Galantamine—Alzheimer's disease	0.000914	0.00391	CcSEcCtD
Erlotinib—Haemorrhage—Galantamine—Alzheimer's disease	0.00091	0.00389	CcSEcCtD
Erlotinib—Hepatitis—Galantamine—Alzheimer's disease	0.00091	0.00389	CcSEcCtD
Erlotinib—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.000905	0.00387	CcSEcCtD
Erlotinib—STK10—nervous system—Alzheimer's disease	0.000904	0.0104	CbGeAlD
Erlotinib—Gastritis—Donepezil—Alzheimer's disease	0.000902	0.00386	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000899	0.00384	CcSEcCtD
Erlotinib—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000898	0.00384	CcSEcCtD
Erlotinib—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000894	0.00382	CcSEcCtD
Erlotinib—CYP1B1—telencephalon—Alzheimer's disease	0.000893	0.0102	CbGeAlD
Erlotinib—Urethral disorder—Galantamine—Alzheimer's disease	0.000892	0.00381	CcSEcCtD
Erlotinib—ULK3—brain—Alzheimer's disease	0.000891	0.0102	CbGeAlD
Erlotinib—Dysphagia—Donepezil—Alzheimer's disease	0.000881	0.00377	CcSEcCtD
Erlotinib—STK10—central nervous system—Alzheimer's disease	0.00087	0.00997	CbGeAlD
Erlotinib—Pancreatitis—Donepezil—Alzheimer's disease	0.000864	0.00369	CcSEcCtD
Erlotinib—Dehydration—Memantine—Alzheimer's disease	0.000861	0.00368	CcSEcCtD
Erlotinib—STK10—cerebellum—Alzheimer's disease	0.00085	0.00974	CbGeAlD
Erlotinib—Eye disorder—Galantamine—Alzheimer's disease	0.00085	0.00364	CcSEcCtD
Erlotinib—Dry skin—Memantine—Alzheimer's disease	0.000848	0.00363	CcSEcCtD
Erlotinib—Hypokalaemia—Memantine—Alzheimer's disease	0.000842	0.0036	CcSEcCtD
Erlotinib—Dehydration—Rivastigmine—Alzheimer's disease	0.000842	0.0036	CcSEcCtD
Erlotinib—MKNK1—brain—Alzheimer's disease	0.000839	0.00961	CbGeAlD
Erlotinib—Dry skin—Rivastigmine—Alzheimer's disease	0.00083	0.00355	CcSEcCtD
Erlotinib—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000824	0.00352	CcSEcCtD
Erlotinib—Gastritis—Memantine—Alzheimer's disease	0.000819	0.0035	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000816	0.00349	CcSEcCtD
Erlotinib—Arrhythmia—Galantamine—Alzheimer's disease	0.000813	0.00348	CcSEcCtD
Erlotinib—MAP2K5—nervous system—Alzheimer's disease	0.000807	0.00924	CbGeAlD
Erlotinib—Gastritis—Rivastigmine—Alzheimer's disease	0.000801	0.00343	CcSEcCtD
Erlotinib—Dysphagia—Memantine—Alzheimer's disease	0.0008	0.00342	CcSEcCtD
Erlotinib—Mental disorder—Galantamine—Alzheimer's disease	0.000797	0.00341	CcSEcCtD
Erlotinib—Weight decreased—Donepezil—Alzheimer's disease	0.000797	0.00341	CcSEcCtD
Erlotinib—SLK—brain—Alzheimer's disease	0.000794	0.0091	CbGeAlD
Erlotinib—Malnutrition—Galantamine—Alzheimer's disease	0.000792	0.00339	CcSEcCtD
Erlotinib—Pneumonia—Donepezil—Alzheimer's disease	0.00079	0.00338	CcSEcCtD
Erlotinib—Infestation—Donepezil—Alzheimer's disease	0.000785	0.00336	CcSEcCtD
Erlotinib—Infestation NOS—Donepezil—Alzheimer's disease	0.000785	0.00336	CcSEcCtD
Erlotinib—Pancreatitis—Memantine—Alzheimer's disease	0.000784	0.00335	CcSEcCtD
Erlotinib—Depression—Donepezil—Alzheimer's disease	0.000783	0.00335	CcSEcCtD
Erlotinib—Dysphagia—Rivastigmine—Alzheimer's disease	0.000782	0.00335	CcSEcCtD
Erlotinib—Flatulence—Galantamine—Alzheimer's disease	0.00078	0.00334	CcSEcCtD
Erlotinib—MAP2K5—central nervous system—Alzheimer's disease	0.000777	0.0089	CbGeAlD
Erlotinib—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000774	0.00331	CcSEcCtD
Erlotinib—Renal failure—Donepezil—Alzheimer's disease	0.000772	0.0033	CcSEcCtD
Erlotinib—Myocardial infarction—Donepezil—Alzheimer's disease	0.00077	0.00329	CcSEcCtD
Erlotinib—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000767	0.00328	CcSEcCtD
Erlotinib—Back pain—Galantamine—Alzheimer's disease	0.000766	0.00328	CcSEcCtD
Erlotinib—Conjunctivitis—Donepezil—Alzheimer's disease	0.000763	0.00326	CcSEcCtD
Erlotinib—MAP2K5—cerebellum—Alzheimer's disease	0.000759	0.0087	CbGeAlD
Erlotinib—Neutropenia—Memantine—Alzheimer's disease	0.000748	0.0032	CcSEcCtD
Erlotinib—Epistaxis—Donepezil—Alzheimer's disease	0.000741	0.00317	CcSEcCtD
Erlotinib—Weight decreased—Memantine—Alzheimer's disease	0.000724	0.00309	CcSEcCtD
Erlotinib—Pneumonia—Memantine—Alzheimer's disease	0.000717	0.00307	CcSEcCtD
Erlotinib—Infestation NOS—Memantine—Alzheimer's disease	0.000713	0.00305	CcSEcCtD
Erlotinib—Infestation—Memantine—Alzheimer's disease	0.000713	0.00305	CcSEcCtD
Erlotinib—Depression—Memantine—Alzheimer's disease	0.000711	0.00304	CcSEcCtD
Erlotinib—Syncope—Galantamine—Alzheimer's disease	0.00071	0.00304	CcSEcCtD
Erlotinib—Haemoglobin—Donepezil—Alzheimer's disease	0.000709	0.00303	CcSEcCtD
Erlotinib—Weight decreased—Rivastigmine—Alzheimer's disease	0.000708	0.00303	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000707	0.00302	CcSEcCtD
Erlotinib—Haemorrhage—Donepezil—Alzheimer's disease	0.000705	0.00301	CcSEcCtD
Erlotinib—Hepatitis—Donepezil—Alzheimer's disease	0.000705	0.00301	CcSEcCtD
Erlotinib—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000703	0.00301	CcSEcCtD
Erlotinib—Pneumonia—Rivastigmine—Alzheimer's disease	0.000702	0.003	CcSEcCtD
Erlotinib—Renal failure—Memantine—Alzheimer's disease	0.000701	0.003	CcSEcCtD
Erlotinib—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000699	0.00299	CcSEcCtD
Erlotinib—Myocardial infarction—Memantine—Alzheimer's disease	0.000699	0.00299	CcSEcCtD
Erlotinib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000698	0.00298	CcSEcCtD
Erlotinib—Infestation—Rivastigmine—Alzheimer's disease	0.000698	0.00298	CcSEcCtD
Erlotinib—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000696	0.00298	CcSEcCtD
Erlotinib—Loss of consciousness—Galantamine—Alzheimer's disease	0.000696	0.00298	CcSEcCtD
Erlotinib—Depression—Rivastigmine—Alzheimer's disease	0.000696	0.00297	CcSEcCtD
Erlotinib—Conjunctivitis—Memantine—Alzheimer's disease	0.000693	0.00296	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000692	0.00296	CcSEcCtD
Erlotinib—Urethral disorder—Donepezil—Alzheimer's disease	0.000691	0.00296	CcSEcCtD
Erlotinib—Cough—Galantamine—Alzheimer's disease	0.000691	0.00296	CcSEcCtD
Erlotinib—STK10—brain—Alzheimer's disease	0.000691	0.00791	CbGeAlD
Erlotinib—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000688	0.00294	CcSEcCtD
Erlotinib—Renal failure—Rivastigmine—Alzheimer's disease	0.000686	0.00293	CcSEcCtD
Erlotinib—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000684	0.00292	CcSEcCtD
Erlotinib—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000684	0.00292	CcSEcCtD
Erlotinib—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000678	0.0029	CcSEcCtD
Erlotinib—ABCB1—blood vessel—Alzheimer's disease	0.000676	0.00774	CbGeAlD
Erlotinib—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000674	0.00288	CcSEcCtD
Erlotinib—Arthralgia—Galantamine—Alzheimer's disease	0.000674	0.00288	CcSEcCtD
Erlotinib—Chest pain—Galantamine—Alzheimer's disease	0.000674	0.00288	CcSEcCtD
Erlotinib—Myalgia—Galantamine—Alzheimer's disease	0.000674	0.00288	CcSEcCtD
Erlotinib—Epistaxis—Memantine—Alzheimer's disease	0.000673	0.00288	CcSEcCtD
Erlotinib—Anxiety—Galantamine—Alzheimer's disease	0.000672	0.00287	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00067	0.00286	CcSEcCtD
Erlotinib—ABCG2—telencephalon—Alzheimer's disease	0.000665	0.00762	CbGeAlD
Erlotinib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00066	0.00282	CcSEcCtD
Erlotinib—Epistaxis—Rivastigmine—Alzheimer's disease	0.000658	0.00281	CcSEcCtD
Erlotinib—ORM1—nervous system—Alzheimer's disease	0.000655	0.0075	CbGeAlD
Erlotinib—Haemoglobin—Memantine—Alzheimer's disease	0.000643	0.00275	CcSEcCtD
Erlotinib—Haemorrhage—Memantine—Alzheimer's disease	0.00064	0.00274	CcSEcCtD
Erlotinib—Hepatitis—Memantine—Alzheimer's disease	0.00064	0.00274	CcSEcCtD
Erlotinib—Shock—Galantamine—Alzheimer's disease	0.000636	0.00272	CcSEcCtD
Erlotinib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000634	0.00271	CcSEcCtD
Erlotinib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000633	0.00271	CcSEcCtD
Erlotinib—Chills—Donepezil—Alzheimer's disease	0.000633	0.00271	CcSEcCtD
Erlotinib—Urinary tract disorder—Memantine—Alzheimer's disease	0.000632	0.0027	CcSEcCtD
Erlotinib—ORM1—central nervous system—Alzheimer's disease	0.000631	0.00723	CbGeAlD
Erlotinib—Arrhythmia—Donepezil—Alzheimer's disease	0.00063	0.00269	CcSEcCtD
Erlotinib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000629	0.00269	CcSEcCtD
Erlotinib—Connective tissue disorder—Memantine—Alzheimer's disease	0.000629	0.00269	CcSEcCtD
Erlotinib—SLCO2B1—nervous system—Alzheimer's disease	0.000628	0.00719	CbGeAlD
Erlotinib—Skin disorder—Galantamine—Alzheimer's disease	0.000628	0.00268	CcSEcCtD
Erlotinib—Urethral disorder—Memantine—Alzheimer's disease	0.000627	0.00268	CcSEcCtD
Erlotinib—Hepatitis—Rivastigmine—Alzheimer's disease	0.000626	0.00268	CcSEcCtD
Erlotinib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000626	0.00268	CcSEcCtD
Erlotinib—Alopecia—Donepezil—Alzheimer's disease	0.000623	0.00266	CcSEcCtD
Erlotinib—ABL1—nervous system—Alzheimer's disease	0.000623	0.00713	CbGeAlD
Erlotinib—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000618	0.00264	CcSEcCtD
Erlotinib—Mental disorder—Donepezil—Alzheimer's disease	0.000618	0.00264	CcSEcCtD
Erlotinib—MAP2K5—brain—Alzheimer's disease	0.000617	0.00707	CbGeAlD
Erlotinib—Anorexia—Galantamine—Alzheimer's disease	0.000616	0.00263	CcSEcCtD
Erlotinib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000615	0.00263	CcSEcCtD
Erlotinib—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000614	0.00263	CcSEcCtD
Erlotinib—Erythema—Donepezil—Alzheimer's disease	0.000614	0.00262	CcSEcCtD
Erlotinib—Malnutrition—Donepezil—Alzheimer's disease	0.000614	0.00262	CcSEcCtD
Erlotinib—Erythema multiforme—Memantine—Alzheimer's disease	0.000605	0.00259	CcSEcCtD
Erlotinib—Flatulence—Donepezil—Alzheimer's disease	0.000605	0.00259	CcSEcCtD
Erlotinib—SLCO2B1—central nervous system—Alzheimer's disease	0.000605	0.00693	CbGeAlD
Erlotinib—ABL1—central nervous system—Alzheimer's disease	0.000599	0.00687	CbGeAlD
Erlotinib—Eye disorder—Memantine—Alzheimer's disease	0.000598	0.00256	CcSEcCtD
Erlotinib—Back pain—Donepezil—Alzheimer's disease	0.000594	0.00254	CcSEcCtD
Erlotinib—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000592	0.00253	CcSEcCtD
Erlotinib—SLCO2B1—cerebellum—Alzheimer's disease	0.000591	0.00677	CbGeAlD
Erlotinib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000589	0.00252	CcSEcCtD
Erlotinib—ABL1—cerebellum—Alzheimer's disease	0.000586	0.00671	CbGeAlD
Erlotinib—Eye disorder—Rivastigmine—Alzheimer's disease	0.000585	0.0025	CcSEcCtD
Erlotinib—Insomnia—Galantamine—Alzheimer's disease	0.000585	0.0025	CcSEcCtD
Erlotinib—Mediastinal disorder—Memantine—Alzheimer's disease	0.000577	0.00247	CcSEcCtD
Erlotinib—Chills—Memantine—Alzheimer's disease	0.000574	0.00246	CcSEcCtD
Erlotinib—Arrhythmia—Memantine—Alzheimer's disease	0.000572	0.00245	CcSEcCtD
Erlotinib—Gefitinib—CYP2D6—Alzheimer's disease	0.000571	0.254	CrCbGaD
Erlotinib—Dyspepsia—Galantamine—Alzheimer's disease	0.000569	0.00243	CcSEcCtD
Erlotinib—Alopecia—Memantine—Alzheimer's disease	0.000566	0.00242	CcSEcCtD
Erlotinib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000564	0.00241	CcSEcCtD
Erlotinib—Chills—Rivastigmine—Alzheimer's disease	0.000562	0.0024	CcSEcCtD
Erlotinib—Decreased appetite—Galantamine—Alzheimer's disease	0.000562	0.0024	CcSEcCtD
Erlotinib—Mental disorder—Memantine—Alzheimer's disease	0.000561	0.0024	CcSEcCtD
Erlotinib—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000559	0.00239	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000558	0.00239	CcSEcCtD
Erlotinib—Malnutrition—Memantine—Alzheimer's disease	0.000557	0.00238	CcSEcCtD
Erlotinib—Fatigue—Galantamine—Alzheimer's disease	0.000557	0.00238	CcSEcCtD
Erlotinib—Alopecia—Rivastigmine—Alzheimer's disease	0.000553	0.00237	CcSEcCtD
Erlotinib—Constipation—Galantamine—Alzheimer's disease	0.000553	0.00236	CcSEcCtD
Erlotinib—Syncope—Donepezil—Alzheimer's disease	0.00055	0.00235	CcSEcCtD
Erlotinib—Flatulence—Memantine—Alzheimer's disease	0.000549	0.00235	CcSEcCtD
Erlotinib—Mental disorder—Rivastigmine—Alzheimer's disease	0.000549	0.00235	CcSEcCtD
Erlotinib—Malnutrition—Rivastigmine—Alzheimer's disease	0.000545	0.00233	CcSEcCtD
Erlotinib—Erythema—Rivastigmine—Alzheimer's disease	0.000545	0.00233	CcSEcCtD
Erlotinib—Loss of consciousness—Donepezil—Alzheimer's disease	0.000539	0.00231	CcSEcCtD
Erlotinib—Back pain—Memantine—Alzheimer's disease	0.000539	0.0023	CcSEcCtD
Erlotinib—Flatulence—Rivastigmine—Alzheimer's disease	0.000537	0.0023	CcSEcCtD
Erlotinib—Cough—Donepezil—Alzheimer's disease	0.000536	0.00229	CcSEcCtD
Erlotinib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000529	0.00226	CcSEcCtD
Erlotinib—Back pain—Rivastigmine—Alzheimer's disease	0.000527	0.00225	CcSEcCtD
Erlotinib—CYP1B1—nervous system—Alzheimer's disease	0.000527	0.00604	CbGeAlD
Erlotinib—Arthralgia—Donepezil—Alzheimer's disease	0.000523	0.00223	CcSEcCtD
Erlotinib—Myalgia—Donepezil—Alzheimer's disease	0.000523	0.00223	CcSEcCtD
Erlotinib—Chest pain—Donepezil—Alzheimer's disease	0.000523	0.00223	CcSEcCtD
Erlotinib—Anxiety—Donepezil—Alzheimer's disease	0.000521	0.00223	CcSEcCtD
Erlotinib—Body temperature increased—Galantamine—Alzheimer's disease	0.000511	0.00218	CcSEcCtD
Erlotinib—Abdominal pain—Galantamine—Alzheimer's disease	0.000511	0.00218	CcSEcCtD
Erlotinib—CYP1B1—central nervous system—Alzheimer's disease	0.000508	0.00581	CbGeAlD
Erlotinib—Oedema—Donepezil—Alzheimer's disease	0.000501	0.00214	CcSEcCtD
Erlotinib—Syncope—Memantine—Alzheimer's disease	0.0005	0.00214	CcSEcCtD
Erlotinib—Infection—Donepezil—Alzheimer's disease	0.000498	0.00213	CcSEcCtD
Erlotinib—CYP1B1—cerebellum—Alzheimer's disease	0.000496	0.00568	CbGeAlD
Erlotinib—CYP2D6—forebrain—Alzheimer's disease	0.000496	0.00568	CbGeAlD
Erlotinib—Shock—Donepezil—Alzheimer's disease	0.000493	0.00211	CcSEcCtD
Erlotinib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000491	0.0021	CcSEcCtD
Erlotinib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00049	0.0021	CcSEcCtD
Erlotinib—Loss of consciousness—Memantine—Alzheimer's disease	0.00049	0.00209	CcSEcCtD
Erlotinib—Syncope—Rivastigmine—Alzheimer's disease	0.000489	0.00209	CcSEcCtD
Erlotinib—Cough—Memantine—Alzheimer's disease	0.000486	0.00208	CcSEcCtD
Erlotinib—SLCO2B1—brain—Alzheimer's disease	0.00048	0.0055	CbGeAlD
Erlotinib—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000479	0.00205	CcSEcCtD
Erlotinib—Anorexia—Donepezil—Alzheimer's disease	0.000477	0.00204	CcSEcCtD
Erlotinib—ABL1—brain—Alzheimer's disease	0.000476	0.00545	CbGeAlD
Erlotinib—Cough—Rivastigmine—Alzheimer's disease	0.000476	0.00203	CcSEcCtD
Erlotinib—Myalgia—Memantine—Alzheimer's disease	0.000474	0.00203	CcSEcCtD
Erlotinib—Arthralgia—Memantine—Alzheimer's disease	0.000474	0.00203	CcSEcCtD
Erlotinib—Chest pain—Memantine—Alzheimer's disease	0.000474	0.00203	CcSEcCtD
Erlotinib—Anxiety—Memantine—Alzheimer's disease	0.000473	0.00202	CcSEcCtD
Erlotinib—Chest pain—Rivastigmine—Alzheimer's disease	0.000464	0.00198	CcSEcCtD
Erlotinib—Arthralgia—Rivastigmine—Alzheimer's disease	0.000464	0.00198	CcSEcCtD
Erlotinib—Myalgia—Rivastigmine—Alzheimer's disease	0.000464	0.00198	CcSEcCtD
Erlotinib—Asthenia—Galantamine—Alzheimer's disease	0.000464	0.00198	CcSEcCtD
Erlotinib—Anxiety—Rivastigmine—Alzheimer's disease	0.000463	0.00198	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000461	0.00197	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000456	0.00195	CcSEcCtD
Erlotinib—CYP2D6—telencephalon—Alzheimer's disease	0.000456	0.00522	CbGeAlD
Erlotinib—Oedema—Memantine—Alzheimer's disease	0.000455	0.00194	CcSEcCtD
Erlotinib—Insomnia—Donepezil—Alzheimer's disease	0.000453	0.00194	CcSEcCtD
Erlotinib—Infection—Memantine—Alzheimer's disease	0.000452	0.00193	CcSEcCtD
Erlotinib—Shock—Memantine—Alzheimer's disease	0.000447	0.00191	CcSEcCtD
Erlotinib—Dyspnoea—Donepezil—Alzheimer's disease	0.000447	0.00191	CcSEcCtD
Erlotinib—Nervous system disorder—Memantine—Alzheimer's disease	0.000446	0.00191	CcSEcCtD
Erlotinib—Thrombocytopenia—Memantine—Alzheimer's disease	0.000445	0.0019	CcSEcCtD
Erlotinib—Oedema—Rivastigmine—Alzheimer's disease	0.000445	0.0019	CcSEcCtD
Erlotinib—Diarrhoea—Galantamine—Alzheimer's disease	0.000442	0.00189	CcSEcCtD
Erlotinib—Infection—Rivastigmine—Alzheimer's disease	0.000442	0.00189	CcSEcCtD
Erlotinib—Skin disorder—Memantine—Alzheimer's disease	0.000442	0.00189	CcSEcCtD
Erlotinib—Dyspepsia—Donepezil—Alzheimer's disease	0.000441	0.00189	CcSEcCtD
Erlotinib—ALB—brain—Alzheimer's disease	0.000439	0.00503	CbGeAlD
Erlotinib—Shock—Rivastigmine—Alzheimer's disease	0.000438	0.00187	CcSEcCtD
Erlotinib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000436	0.00187	CcSEcCtD
Erlotinib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000436	0.00186	CcSEcCtD
Erlotinib—Decreased appetite—Donepezil—Alzheimer's disease	0.000435	0.00186	CcSEcCtD
Erlotinib—Anorexia—Memantine—Alzheimer's disease	0.000434	0.00185	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000432	0.00185	CcSEcCtD
Erlotinib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000432	0.00185	CcSEcCtD
Erlotinib—Fatigue—Donepezil—Alzheimer's disease	0.000432	0.00185	CcSEcCtD
Erlotinib—Pain—Donepezil—Alzheimer's disease	0.000428	0.00183	CcSEcCtD
Erlotinib—Constipation—Donepezil—Alzheimer's disease	0.000428	0.00183	CcSEcCtD
Erlotinib—Dizziness—Galantamine—Alzheimer's disease	0.000427	0.00183	CcSEcCtD
Erlotinib—Anorexia—Rivastigmine—Alzheimer's disease	0.000424	0.00181	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000414	0.00177	CcSEcCtD
Erlotinib—Insomnia—Memantine—Alzheimer's disease	0.000411	0.00176	CcSEcCtD
Erlotinib—Vomiting—Galantamine—Alzheimer's disease	0.000411	0.00176	CcSEcCtD
Erlotinib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00041	0.00175	CcSEcCtD
Erlotinib—Rash—Galantamine—Alzheimer's disease	0.000408	0.00174	CcSEcCtD
Erlotinib—Dermatitis—Galantamine—Alzheimer's disease	0.000407	0.00174	CcSEcCtD
Erlotinib—Dyspnoea—Memantine—Alzheimer's disease	0.000405	0.00173	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000405	0.00173	CcSEcCtD
Erlotinib—Headache—Galantamine—Alzheimer's disease	0.000405	0.00173	CcSEcCtD
Erlotinib—ABCB1—embryo—Alzheimer's disease	0.000403	0.00462	CbGeAlD
Erlotinib—CYP1B1—brain—Alzheimer's disease	0.000403	0.00462	CbGeAlD
Erlotinib—Insomnia—Rivastigmine—Alzheimer's disease	0.000402	0.00172	CcSEcCtD
Erlotinib—Dyspepsia—Memantine—Alzheimer's disease	0.0004	0.00171	CcSEcCtD
Erlotinib—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000397	0.0017	CcSEcCtD
Erlotinib—Body temperature increased—Donepezil—Alzheimer's disease	0.000396	0.00169	CcSEcCtD
Erlotinib—Abdominal pain—Donepezil—Alzheimer's disease	0.000396	0.00169	CcSEcCtD
Erlotinib—Decreased appetite—Memantine—Alzheimer's disease	0.000395	0.00169	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000393	0.00168	CcSEcCtD
Erlotinib—Fatigue—Memantine—Alzheimer's disease	0.000392	0.00168	CcSEcCtD
Erlotinib—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000392	0.00167	CcSEcCtD
Erlotinib—Pain—Memantine—Alzheimer's disease	0.000389	0.00166	CcSEcCtD
Erlotinib—Constipation—Memantine—Alzheimer's disease	0.000389	0.00166	CcSEcCtD
Erlotinib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000387	0.00165	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000384	0.00164	CcSEcCtD
Erlotinib—Nausea—Galantamine—Alzheimer's disease	0.000384	0.00164	CcSEcCtD
Erlotinib—Fatigue—Rivastigmine—Alzheimer's disease	0.000384	0.00164	CcSEcCtD
Erlotinib—Pain—Rivastigmine—Alzheimer's disease	0.00038	0.00163	CcSEcCtD
Erlotinib—Constipation—Rivastigmine—Alzheimer's disease	0.00038	0.00163	CcSEcCtD
Erlotinib—CYP1A1—nervous system—Alzheimer's disease	0.000373	0.00427	CbGeAlD
Erlotinib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000372	0.00159	CcSEcCtD
Erlotinib—ABCG2—cerebellum—Alzheimer's disease	0.000369	0.00423	CbGeAlD
Erlotinib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000364	0.00156	CcSEcCtD
Erlotinib—Body temperature increased—Memantine—Alzheimer's disease	0.00036	0.00154	CcSEcCtD
Erlotinib—Abdominal pain—Memantine—Alzheimer's disease	0.00036	0.00154	CcSEcCtD
Erlotinib—Asthenia—Donepezil—Alzheimer's disease	0.000359	0.00154	CcSEcCtD
Erlotinib—CYP1A1—central nervous system—Alzheimer's disease	0.000359	0.00411	CbGeAlD
Erlotinib—ABCB1—forebrain—Alzheimer's disease	0.000357	0.00408	CbGeAlD
Erlotinib—Pruritus—Donepezil—Alzheimer's disease	0.000354	0.00152	CcSEcCtD
Erlotinib—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000352	0.0015	CcSEcCtD
Erlotinib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000352	0.0015	CcSEcCtD
Erlotinib—Diarrhoea—Donepezil—Alzheimer's disease	0.000343	0.00147	CcSEcCtD
Erlotinib—Dizziness—Donepezil—Alzheimer's disease	0.000331	0.00142	CcSEcCtD
Erlotinib—ABCB1—telencephalon—Alzheimer's disease	0.000328	0.00376	CbGeAlD
Erlotinib—Asthenia—Memantine—Alzheimer's disease	0.000326	0.0014	CcSEcCtD
Erlotinib—Pruritus—Memantine—Alzheimer's disease	0.000322	0.00138	CcSEcCtD
Erlotinib—Asthenia—Rivastigmine—Alzheimer's disease	0.000319	0.00137	CcSEcCtD
Erlotinib—Vomiting—Donepezil—Alzheimer's disease	0.000318	0.00136	CcSEcCtD
Erlotinib—Rash—Donepezil—Alzheimer's disease	0.000316	0.00135	CcSEcCtD
Erlotinib—Dermatitis—Donepezil—Alzheimer's disease	0.000316	0.00135	CcSEcCtD
Erlotinib—Pruritus—Rivastigmine—Alzheimer's disease	0.000315	0.00135	CcSEcCtD
Erlotinib—Headache—Donepezil—Alzheimer's disease	0.000314	0.00134	CcSEcCtD
Erlotinib—Diarrhoea—Memantine—Alzheimer's disease	0.000311	0.00133	CcSEcCtD
Erlotinib—CYP2C8—brain—Alzheimer's disease	0.000309	0.00353	CbGeAlD
Erlotinib—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000304	0.0013	CcSEcCtD
Erlotinib—Dizziness—Memantine—Alzheimer's disease	0.000301	0.00129	CcSEcCtD
Erlotinib—ABCG2—brain—Alzheimer's disease	0.0003	0.00344	CbGeAlD
Erlotinib—Nausea—Donepezil—Alzheimer's disease	0.000298	0.00127	CcSEcCtD
Erlotinib—Dizziness—Rivastigmine—Alzheimer's disease	0.000294	0.00126	CcSEcCtD
Erlotinib—Vomiting—Memantine—Alzheimer's disease	0.000289	0.00124	CcSEcCtD
Erlotinib—Rash—Memantine—Alzheimer's disease	0.000287	0.00123	CcSEcCtD
Erlotinib—Dermatitis—Memantine—Alzheimer's disease	0.000286	0.00123	CcSEcCtD
Erlotinib—Headache—Memantine—Alzheimer's disease	0.000285	0.00122	CcSEcCtD
Erlotinib—CYP1A1—brain—Alzheimer's disease	0.000285	0.00326	CbGeAlD
Erlotinib—Vomiting—Rivastigmine—Alzheimer's disease	0.000283	0.00121	CcSEcCtD
Erlotinib—Rash—Rivastigmine—Alzheimer's disease	0.000281	0.0012	CcSEcCtD
Erlotinib—Dermatitis—Rivastigmine—Alzheimer's disease	0.00028	0.0012	CcSEcCtD
Erlotinib—Headache—Rivastigmine—Alzheimer's disease	0.000279	0.00119	CcSEcCtD
Erlotinib—CYP3A4—nervous system—Alzheimer's disease	0.000273	0.00313	CbGeAlD
Erlotinib—Nausea—Memantine—Alzheimer's disease	0.00027	0.00116	CcSEcCtD
Erlotinib—CYP2D6—nervous system—Alzheimer's disease	0.000269	0.00308	CbGeAlD
Erlotinib—Nausea—Rivastigmine—Alzheimer's disease	0.000264	0.00113	CcSEcCtD
Erlotinib—CYP3A4—central nervous system—Alzheimer's disease	0.000263	0.00302	CbGeAlD
Erlotinib—CYP2D6—central nervous system—Alzheimer's disease	0.000259	0.00297	CbGeAlD
Erlotinib—CYP2D6—cerebellum—Alzheimer's disease	0.000253	0.0029	CbGeAlD
Erlotinib—CYP2D6—brain—Alzheimer's disease	0.000206	0.00236	CbGeAlD
Erlotinib—ABCB1—nervous system—Alzheimer's disease	0.000194	0.00222	CbGeAlD
Erlotinib—ABCB1—central nervous system—Alzheimer's disease	0.000186	0.00213	CbGeAlD
Erlotinib—ABCB1—cerebellum—Alzheimer's disease	0.000182	0.00209	CbGeAlD
Erlotinib—ABCB1—brain—Alzheimer's disease	0.000148	0.00169	CbGeAlD
Erlotinib—CYP1B1—Metabolism—CALM1—Alzheimer's disease	7.3e-06	3.75e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—APOE—Alzheimer's disease	7.28e-06	3.73e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CREB1—Alzheimer's disease	7.27e-06	3.73e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—INS—Alzheimer's disease	7.23e-06	3.71e-05	CbGpPWpGaD
Erlotinib—JAK3—Immune System—AKT1—Alzheimer's disease	7.22e-06	3.71e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	7.21e-06	3.7e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CAV1—Alzheimer's disease	7.21e-06	3.7e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	7.2e-06	3.7e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—AKT1—Alzheimer's disease	7.18e-06	3.69e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CYP2D6—Alzheimer's disease	7.16e-06	3.68e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MTHFR—Alzheimer's disease	7.11e-06	3.65e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LPL—Alzheimer's disease	7.07e-06	3.63e-05	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—AKT1—Alzheimer's disease	7.05e-06	3.62e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—TPI1—Alzheimer's disease	7.03e-06	3.61e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CHAT—Alzheimer's disease	7.03e-06	3.61e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	7.03e-06	3.61e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CASP3—Alzheimer's disease	7.03e-06	3.61e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MEF2C—Alzheimer's disease	7.01e-06	3.6e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.89e-06	3.54e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—Alzheimer's disease	6.88e-06	3.53e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PRKCG—Alzheimer's disease	6.88e-06	3.53e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1B—Alzheimer's disease	6.84e-06	3.51e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ACHE—Alzheimer's disease	6.83e-06	3.51e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—BCHE—Alzheimer's disease	6.83e-06	3.51e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	6.81e-06	3.5e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PPARG—Alzheimer's disease	6.8e-06	3.49e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—BCHE—Alzheimer's disease	6.79e-06	3.49e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—INPP5D—Alzheimer's disease	6.75e-06	3.47e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MAOB—Alzheimer's disease	6.74e-06	3.46e-05	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	6.73e-06	3.46e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—Alzheimer's disease	6.71e-06	3.45e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—Alzheimer's disease	6.71e-06	3.44e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NGF—Alzheimer's disease	6.7e-06	3.44e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—INS—Alzheimer's disease	6.66e-06	3.42e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—Alzheimer's disease	6.65e-06	3.42e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CALM1—Alzheimer's disease	6.64e-06	3.41e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	6.63e-06	3.4e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—APOE—Alzheimer's disease	6.62e-06	3.4e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—BCL2—Alzheimer's disease	6.61e-06	3.4e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CAV1—Alzheimer's disease	6.56e-06	3.37e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR5—Alzheimer's disease	6.52e-06	3.35e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	6.49e-06	3.33e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MAPK8—Alzheimer's disease	6.46e-06	3.32e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	6.44e-06	3.31e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ACHE—Alzheimer's disease	6.44e-06	3.3e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.42e-06	3.29e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PLCB1—Alzheimer's disease	6.41e-06	3.29e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS1—Alzheimer's disease	6.4e-06	3.28e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ENO1—Alzheimer's disease	6.4e-06	3.28e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2A—Alzheimer's disease	6.38e-06	3.27e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	6.36e-06	3.27e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.36e-06	3.26e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—AKT1—Alzheimer's disease	6.35e-06	3.26e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS3—Alzheimer's disease	6.34e-06	3.26e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PPARG—Alzheimer's disease	6.34e-06	3.25e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.32e-06	3.24e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.28e-06	3.23e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	6.28e-06	3.22e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—MAPK8—Alzheimer's disease	6.27e-06	3.22e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—A2M—Alzheimer's disease	6.27e-06	3.22e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	6.25e-06	3.21e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—INS—Alzheimer's disease	6.22e-06	3.19e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	6.21e-06	3.19e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ABCA1—Alzheimer's disease	6.21e-06	3.19e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—AKT1—Alzheimer's disease	6.19e-06	3.18e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	6.19e-06	3.18e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—AKT1—Alzheimer's disease	6.14e-06	3.15e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ENO1—Alzheimer's disease	6.03e-06	3.1e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	6.03e-06	3.1e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—VEGFA—Alzheimer's disease	5.96e-06	3.06e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CALM1—Alzheimer's disease	5.95e-06	3.05e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—BCHE—Alzheimer's disease	5.95e-06	3.05e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LEP—Alzheimer's disease	5.93e-06	3.04e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APOE—Alzheimer's disease	5.93e-06	3.04e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—Alzheimer's disease	5.88e-06	3.02e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CAV1—Alzheimer's disease	5.87e-06	3.02e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	5.87e-06	3.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1B—Alzheimer's disease	5.85e-06	3e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—NOS3—Alzheimer's disease	5.84e-06	3e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	5.84e-06	3e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—Alzheimer's disease	5.8e-06	2.98e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PPARG—Alzheimer's disease	5.77e-06	2.96e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ESR1—Alzheimer's disease	5.66e-06	2.91e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—LPL—Alzheimer's disease	5.66e-06	2.9e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—INS—Alzheimer's disease	5.66e-06	2.9e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PLCB1—Alzheimer's disease	5.61e-06	2.88e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—BCHE—Alzheimer's disease	5.61e-06	2.88e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—F2—Alzheimer's disease	5.59e-06	2.87e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.59e-06	2.87e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TP53—Alzheimer's disease	5.53e-06	2.84e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—Alzheimer's disease	5.47e-06	2.81e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOTCH1—Alzheimer's disease	5.47e-06	2.81e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ACHE—Alzheimer's disease	5.45e-06	2.8e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—NOS3—Alzheimer's disease	5.45e-06	2.8e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ABCA1—Alzheimer's disease	5.44e-06	2.79e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—VEGFA—Alzheimer's disease	5.44e-06	2.79e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.43e-06	2.79e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.43e-06	2.79e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—AKT1—Alzheimer's disease	5.42e-06	2.78e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	5.39e-06	2.77e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	5.38e-06	2.76e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—MAPK8—Alzheimer's disease	5.36e-06	2.75e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	5.36e-06	2.75e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARGC1A—Alzheimer's disease	5.35e-06	2.75e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—Alzheimer's disease	5.35e-06	2.74e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—LPL—Alzheimer's disease	5.35e-06	2.74e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—HMOX1—Alzheimer's disease	5.33e-06	2.73e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	5.29e-06	2.72e-05	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—AKT1—Alzheimer's disease	5.21e-06	2.67e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.2e-06	2.67e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—GSK3B—Alzheimer's disease	5.13e-06	2.64e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.13e-06	2.63e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ENO1—Alzheimer's disease	5.11e-06	2.62e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	5.11e-06	2.62e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	5.09e-06	2.62e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CREB1—Alzheimer's disease	5.09e-06	2.61e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—INS—Alzheimer's disease	5.07e-06	2.6e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—Alzheimer's disease	5.06e-06	2.6e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	5.01e-06	2.57e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.01e-06	2.57e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—Alzheimer's disease	4.99e-06	2.56e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—Alzheimer's disease	4.99e-06	2.56e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL2—Alzheimer's disease	4.98e-06	2.56e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—NOS3—Alzheimer's disease	4.96e-06	2.55e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—LPL—Alzheimer's disease	4.9e-06	2.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IGF1—Alzheimer's disease	4.9e-06	2.51e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—LPL—Alzheimer's disease	4.87e-06	2.5e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.84e-06	2.48e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	4.81e-06	2.47e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CALM1—Alzheimer's disease	4.76e-06	2.44e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—BCHE—Alzheimer's disease	4.75e-06	2.44e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—APOE—Alzheimer's disease	4.74e-06	2.43e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CAV1—Alzheimer's disease	4.7e-06	2.41e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	4.69e-06	2.41e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—HMOX1—Alzheimer's disease	4.67e-06	2.4e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—AKT1—Alzheimer's disease	4.67e-06	2.4e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—Alzheimer's disease	4.54e-06	2.33e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TP53—Alzheimer's disease	4.51e-06	2.31e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CALM1—Alzheimer's disease	4.5e-06	2.31e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	4.48e-06	2.3e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOE—Alzheimer's disease	4.48e-06	2.3e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOS3—Alzheimer's disease	4.44e-06	2.28e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CAV1—Alzheimer's disease	4.44e-06	2.28e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.42e-06	2.27e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	4.41e-06	2.27e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.4e-06	2.26e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.4e-06	2.26e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MTHFR—Alzheimer's disease	4.39e-06	2.25e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	4.34e-06	2.23e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LPL—Alzheimer's disease	4.27e-06	2.19e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.21e-06	2.16e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—Alzheimer's disease	4.19e-06	2.15e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.16e-06	2.13e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARG—Alzheimer's disease	4.13e-06	2.12e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—Alzheimer's disease	4.12e-06	2.12e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CALM1—Alzheimer's disease	4.12e-06	2.12e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TP53—Alzheimer's disease	4.11e-06	2.11e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOE—Alzheimer's disease	4.11e-06	2.11e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CALM1—Alzheimer's disease	4.1e-06	2.1e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOE—Alzheimer's disease	4.08e-06	2.1e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CAV1—Alzheimer's disease	4.07e-06	2.09e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—INS—Alzheimer's disease	4.05e-06	2.08e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CAV1—Alzheimer's disease	4.05e-06	2.08e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.02e-06	2.07e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—Alzheimer's disease	4.01e-06	2.06e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.94e-06	2.02e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.94e-06	2.02e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARG—Alzheimer's disease	3.9e-06	2e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.87e-06	1.98e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.84e-06	1.97e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—INS—Alzheimer's disease	3.83e-06	1.96e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—AKT1—Alzheimer's disease	3.81e-06	1.95e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CASP3—Alzheimer's disease	3.77e-06	1.94e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—Alzheimer's disease	3.75e-06	1.92e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.74e-06	1.92e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.73e-06	1.91e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—AKT1—Alzheimer's disease	3.7e-06	1.9e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.67e-06	1.88e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.62e-06	1.86e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CALM1—Alzheimer's disease	3.59e-06	1.84e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOE—Alzheimer's disease	3.58e-06	1.84e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARG—Alzheimer's disease	3.58e-06	1.84e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARG—Alzheimer's disease	3.56e-06	1.83e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NOS3—Alzheimer's disease	3.55e-06	1.82e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CAV1—Alzheimer's disease	3.55e-06	1.82e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—INS—Alzheimer's disease	3.51e-06	1.8e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—INS—Alzheimer's disease	3.49e-06	1.79e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—AKT1—Alzheimer's disease	3.47e-06	1.78e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MAPK8—Alzheimer's disease	3.47e-06	1.78e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.46e-06	1.78e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—AKT1—Alzheimer's disease	3.46e-06	1.77e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—Alzheimer's disease	3.42e-06	1.76e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.41e-06	1.75e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.38e-06	1.74e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.37e-06	1.73e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NOS3—Alzheimer's disease	3.36e-06	1.72e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.35e-06	1.72e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.34e-06	1.72e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	3.25e-06	1.67e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VEGFA—Alzheimer's disease	3.2e-06	1.64e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—Alzheimer's disease	3.16e-06	1.62e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—AKT1—Alzheimer's disease	3.16e-06	1.62e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.12e-06	1.6e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NOS3—Alzheimer's disease	3.08e-06	1.58e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	3.07e-06	1.58e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.07e-06	1.58e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NOS3—Alzheimer's disease	3.06e-06	1.57e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—INS—Alzheimer's disease	3.06e-06	1.57e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.94e-06	1.51e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—Alzheimer's disease	2.94e-06	1.51e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—AKT1—Alzheimer's disease	2.92e-06	1.5e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.89e-06	1.48e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—INS—Alzheimer's disease	2.88e-06	1.48e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.88e-06	1.48e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.87e-06	1.47e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.86e-06	1.47e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.83e-06	1.45e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	2.81e-06	1.44e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—Alzheimer's disease	2.8e-06	1.44e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—AKT1—Alzheimer's disease	2.69e-06	1.38e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.68e-06	1.38e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.63e-06	1.35e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.53e-06	1.3e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—AKT1—Alzheimer's disease	2.51e-06	1.29e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.49e-06	1.28e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.45e-06	1.26e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—INS—Alzheimer's disease	2.44e-06	1.25e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TP53—Alzheimer's disease	2.42e-06	1.24e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.37e-06	1.22e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.31e-06	1.19e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—AKT1—Alzheimer's disease	2.28e-06	1.17e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—Alzheimer's disease	2.21e-06	1.14e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.21e-06	1.14e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.2e-06	1.13e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.18e-06	1.12e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.14e-06	1.1e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AKT1—Alzheimer's disease	2.04e-06	1.05e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.96e-06	1e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.92e-06	9.86e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—INS—Alzheimer's disease	1.88e-06	9.67e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.65e-06	8.48e-06	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.63e-06	8.38e-06	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—AKT1—Alzheimer's disease	1.54e-06	7.92e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.51e-06	7.76e-06	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.41e-06	7.26e-06	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AKT1—Alzheimer's disease	1.41e-06	7.22e-06	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.23e-06	6.33e-06	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.16e-06	5.96e-06	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AKT1—Alzheimer's disease	9.84e-07	5.05e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	7.59e-07	3.9e-06	CbGpPWpGaD
